An efficient access to novel families of cyano‐containing polyheteroaromatic D−A molecules with extended π‐conjugation, including dibenzo[ c,h ][1,6]naphthyridine derivatives, has been elaborated. The synthetic strategy is based on the sequence of metal‐catalyzed annulation and cross‐coupling reactions starting from available 4‐ethynyl‐5,6‐difluoro‐7‐( p ‐methoxyphenyl)‐2,1,3‐benzothiadiazole to get a new series of isoquinoline‐linked BTD‐based D−A compounds, which further undergo a selective cyanation to afford the corresponding mono‐CN‐ or di‐CN‐BTD derivatives depending on the reaction conditions. In course of the investigation of cyanation process, a new type of intramolecular heterocyclization included the transformation of the benzothiadiazole core into hardly accessible dibenzo[ c,h ][1,6]naphthyridine framework has been unexpectedly discovered. The protocols developed tolerate a wide range of donor blocks such as diphenylamine, carbazole, dibenzoazepine and dihydroacridine.
No takes yet. Share an insight, caveat, or question.
Gribanov et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: